美股市场个股详情

GUTS Fractyl Health

添加自选

6.900
+0.280+4.23%

交易中 05/15 12:42 (美东)

3.30亿总市值3.14市盈率TTM

Fractyl Health股票讨论区

登录发表评论

Trytosaveabit

05/13 17:14

Looks way more impressive than it is! Hehehe. But who knows, it is a great increase.

$Fractyl Health(GUTS.US)$ Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.17) per share. This is a 97.84 percent increase over losses of $(7.87) per share from the same period last year. The company reported $33.000 thousand in sales this quarter. This is a 560.00 percent increase over sales of $5.000 thousand the same period last year.

Stock Region

04/02 06:50

Health Company Receives FDA Approval For Obesity Drug Study

A Revolutionary Step in Obesity Management: The Approval of Fractyl Health's Revita® Remain-1 Study.
In a groundbreaking development for the field of obesity management, Fractyl Health has received FDA Investigational Device Exemption (IDE) approval for its pivotal Revita® Remain-1 study. This marks a significant milestone in providing durable weight maintenance solutions for patients after the discontinuation of GLP-1 based drugs. With ...

Trytosaveabit

04/01 06:45

How s*itty of a trick! Hehehe

$Fractyl Health(GUTS.US)$ No longer looking for reversal! They release FDA news to get the PI! Then they release the big ole earnings loss! Hehehe!

Trytosaveabit

04/01 05:17

Looking for reversal

$Fractyl Health(GUTS.US)$ Fractyl Health Receives FDA IDE Approval for the Revita Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
Globe Newswire 1-Apr-2024 6:00 AM